Test Utilization Resources for Clinicians
What is the Communiqué?
The Communiqué is published six times per year. Articles are developed by our laboratory professionals and practicing clinicians. Each issue of the Communiqué provides laboratorians and physicians with an original scientific feature article, a section on laboratory test utilization, information on new diagnostic tests, and descriptions of continuing medical education programs and workshops.
A complimentary subscription to the print copy is provided to Mayo Medical Laboratories’ clients and the publication is also is available to read on line, to listen to an audio recording, or to download as a podcast.
Mayo Medical Laboratories is approved as a provider of continuing education programs in the Clinical Laboratory Sciences by the ASCLS P.A.C.E. ® program and provides 0.5 contact hours credit for listening to or reading the Communiqué.
How do I use the Communiqué?
Communiqué articles are meant to be shared with appropriate clinical and laboratory colleagues to provide insight on new and emerging clinical topics.
How Can I Share the Communiqué with Colleagues?
This information can be shared with colleagues by clicking the “email page” button at the top of each page.
Emergence of a New Pathogenic Ehrlichia Species, Wisconsin and Minnesota, 2009
A new pathogenic Ehrlichia species (subsequently referred to as ehrlichia species Wisconsin) has been identified in patients from Wisconsin and Minnesota. The identification of ehrlichia species Wisconsin in humans has important clinical and epidemiologic implications. Previously, human disease caused by any Ehrlichia species was not thought to be present in Minnesota and Wisconsin. Therefore, physicians in these states need to know to test for ehrlichiosis so the diagnosis is not missed.
Published on May 01, 2013
Practical Guide to the Analytical Validation of Body Fluid Chemistry Testing
Analytical validation of body fluids can be challenging but, in general, should follow the same processes required for other clinical specimens. The various clinical scenarios must be considered to provide body fluid tests that have pertinent interpretive information. Requests to perform assays using specimen types that have not been validated should be discouraged. Testing should be done only when there are extenuating circumstances, with disclaimers included in the report regarding the possible inaccuracy of the results.
Published on March 4, 2013Learn more...
Listen to the Audio Communiqué